Pekari and Schmidt
4.05 (m, 3H), 4.12-4.25 (m, 3H), 4.34-4.52 (m, 3H), 4.62-
4.75 (m, 5H), 4.76-5.02 (m, 3H), 5.11-5.29 (m, 3H), 5.41 (d,
J 1,2 ) 3.7 Hz, 1H, 1b-H), 6.70-6.79 (m, 2H, PA), 6.93-7.00
(m, 1H, PA), 7.12-7.39 (m, 32H, Ph), 7.41-7.51 (m, 2H, Bz),
7.52-7.65 (m, 1H, Bz), 8.01-8.05 (m, 2H, Bz). Anal. Calcd for
(m, 4H, TBDPS), 8.00-8.05 (m, 2H, Bz); HMQC data (13C
(150.9 MHz)/1H (600 MHz)) 75.1/5.05 (1a), 74.1/4.21 (2a), 80.8/
3.61 (3a), 81.9/4.16 (4a), 79.7/3.49 (5a), 75.1/4.45 (6a), 98.6/
5.33 (1b), 54.5/3.92 (2b), 81.5/3.48 (3b), 73.3/3.83 (4b), 70.6/
3.99 (5b), 68.6/3.30 (6b), 98.1/5.29 (1c), 70.2/5.48 (2c), 75.4/3.75
(3c), 72.9/4.01 (4c), 70.8/3.58 (5c), 66.4/3.80 + 3.16 (6c), 100.8/
4.65 (1d), 52.4/4.26 (2d), 81.5/3.48 (3d), 71.9/3.49 (4d), 73.5/
3.52 (5d), 68.9/3.48 + 3.30 (6d), 99.3/4.55 (1e), 72.7/4.07 (2e),
80.1/3.80 (3e), 75.4/3.42 (4e), 72.5/3.70 (5e), 70.9/3.63 + 3.49
(6e), 100.2/5.28 (1f), 74.4/4.10 (2f), -/3.88 (3f), 74.3/4.13 (4f),
73.1/3.65 (5f), (6f), 99.6/5.22 (1g), 74.7/3.86 (2g), -/3.88 (3g),
74.7/4.00 (4g), 72.1/3.81 (5g), 68.9/3.56 + 3.48 (6g). Anal. Calcd
C
69H67O13N3 (1146.39): C 72.29, H 5.90, N 3.67. Found: C
72.22, H 5.88, N 3.42.
(2-Azid o-3,6-d i-O-ben zyl-2-d eoxy-r-D-glu cop yr a n osyl)-
(1f6)-1-O-ben zoyl-2,3,4,5-tetr a-O-ben zyl-myo-in ositol (37).
Compound 36 (234 mg, 204 µmol) was stirred at 0 °C for 15
min in 5 mL of MeNH2 solution (33% in dry ethanol) and the
solvent was rapidly removed at room temperature. Flash
chromatography (petroleum ether/ethyl acetate 4:1) afforded
compound 37 (197 mg, 194 µmol, 96%) as ca olorless foam.
TLC [petroleum ether/ethyl acetate (5:2)] Rf 0.62; [R]D +5.8 (c
for
C213H226O40N2Si (3482.50): C 73.46, H 6.55, N 0.80.
Found: C 73.23, H 6.50, N 0.65. MALDI-Tof-MS [positive
mode, matrix: 4-nitroaniline with NaI in MeOH] m/z 3504 [M
+ Na]+.
1
1.2, CDCl3); H NMR (250 MHz, CDCl3) δ 2.00 (d, J OH ) 3.2
Hz, 1H, OH), 3.05-3.20 (m, 3H), 3.52-3.72 (m, 4H), 3.80-
3.91 (m, 1H), 4.18-4.26 (m, 3H), 4.36-4.49 (m, 2H), 4.65-
4.87 (m, 8H), 4.96-5.20 (m, 3H), 5.36 (d, J 1,2 ) 3.8 Hz, 1H,
1b-H), 7.14-7.36 (m, 30H, Ph), 7.43-7.49 (m, 2H, Bz), 7.56-
7.63 (m, 1H, Bz), 8.02-8.05 (m, 2H, Bz). Anal. Calcd for
(2,3,4,6-Tet r a -O-b en zyl-r-D-m a n n op yr a n osyl)-(1f2)-
(3,4-d i-O-ben zyl-r-D-m a n n op yr a n osyl)-(1f2)-(3,4,6-tr i-O-
ben zyl-r-D-m a n n op yr a n osyl)-(1f6)-[(2-a ceta m id o-3,4,6-
tr i-O-ben zyl-2-d eoxy-â-D-ga la ctop yr a n osyl)-(1f4)]-(3-O-
ben zyl-2-O-p h en oxya cetyl-r-D-m a n n op yr a n osyl)-(1f4)-
(3,6-d i-O-b e n zyl-2-N -(t er t -b u t yloxyca r b on yl)a m in o-2-
d eoxy-r-D-glu cop yr a n osyl)-(1f6)-2,3,4,5-tetr a -O-ben zyl-
1-O-ben zoyl-m yo-in ositol (40). Compound 39 (190 mg, 55
µmol) was dissolved in 2 mL of THF, 440 µL (440 µmol) of
TBAF solution (1 N in THF), and 25 µL (433 µmol, 8 equiv) of
acetic acid. After stirring at 45 °C for 2 to 6 days, removal of
the solvent at room temperature, and flash chromatography
(petroleum ether/ethyl acetate 3:1 f 2:1) compound 40 (137
mg, 43 µmol, 75%) was obtained, which could be lyophilized
from dioxane. TLC [petroleum ether/ethyl acetate (2:1)] Rf 0.52;
[R]D +15 (c 0.9, CDCl3); 1H NMR (250 MHz, CDCl3) δ 1.09 (s,
C
61H61O11N3 (1012.25): C 72.37, H 6.09, N 4.15. Found: C
72.31, H 5.97, N 3.71.
(2-Azid o-3,6-d i-O-ben zyl-2-N-(ter t-bu tyloxyca r bon yl)-
a m in o-2-d eoxy-r-D-glu cop yr a n osyl)-(1f6)-1-O-ben zoyl-
2,3,4,5-tetr a -O-ben zyl-m yo-in ositol (6). Compound 37 (25
mg, 242 µmol) was dissolved in 5 mL of pyridine/water 4/1 and
propanedithiol (500 µL, 5 mmol) and 10 drops of triethylamine
were added. After stirring at 45 °C for 2 days in a tightly closed
flask (free amine: TLC [petroleum ether/ethyl acetate (5:2)]
Rf 0.05) the solution was coevaporated three times with dry
toluene and the residue dissolved in 3 mL of dry toluene. Boc2O
(370 mg, 1.7 mmol) was added, the solution was stirred at room
temperature for 4 h, and the solvent was removed. Flash
chromatography (petroleum ether/ethyl acetate 3:1) afforded
compound 6 (215 mg, 199 µmol, 82%) as a colorless foam. TLC
[petroleum ether/ethyl acetate (5:2)] Rf 0.38; [R]D +12 (c 1.6,
CDCl3); 1H NMR (250 MHz, CDCl3) δ 1.16 + 1.13 (s, 9H, tBu),
2.07 (d, J OH ) 3.0 Hz, 1H, OH), 3.18-3.25 (m, 1H, 6b-H),
3.30-3.52 (m, 3H, 3b,5a,6′b-H), 3.58-3.75 (m, 2H, 3a,4b-H),
3.80-4.00 (m, 2H, 2b,5b-H), 4.14-4.32 (m, 3H, 2a,4a-H),
4.41-4.72 (m, 9H), 4.75-4.85 (m, 2H), 4.95-5.08 (m, 3H, 1a-
H), 5.33 (d, J 1,2 ) 3.6 Hz, 1H, 1b-H), 7.03-7.35 (m, 30H, Ph),
7.38-7.48 (m, 2H, Bz), 7.50-7.61 (m, 1H, Bz), 7.95-8.05 (m,
2H, Bz); HMQC data (13C (150.9 MHz)/1H (600 MHz)) 75.5/
5.03 (1a), 74.3/4.20 (2a), 80.8/3.61 (3a), 81.9/4.17 (4a), 81.5/
3.47 (5a), 74.4/4.48 (6a), 98.7/5.33 (1b), 53.4/3.86 (2b), 80.6/
3.38 (3b), 70.9/3.70 (4b), 70.5/3.96 (5b), 69.0/3.33 + 3.23 (6b).
Anal. Calcd for C66H71O13N (1086.38): C 72.96, H 6.60, N 1.29.
Found: C 72.67, H 6.52, N 1.06.
t
9H, Bu), 1.66 (s, 3H, NAc), 3.20-5.15 (m, 83H), 5.28-5.34
(m, 2H), 5.46 (br s, 1H), 6.12 (d, J NH ) 8.3 Hz, 1H, NH), 6.53-
6.62 (m, 2H, PA), 6.75-6.82 (m, 1H, PA), 6.87-7.51 (m, 103H,
Ph), 8.01-8.04 (m, 2H, Bz). Anal. Calcd for C197H208O40N2
(3244.07): C 72.93, H 6.48, N 0.86. Found: C 72.71, H 6.38,
N 0.60. MALDI-TOF-MS [positive mode, matrix: 4-nitroa-
niline with NaI in MeOH] m/z 3266 [M + Na]+.
Tr iet h yla m m on iu m (2,3,4,6-Tet r a -O-b en zyl-r-D-m a n -
n opyr an osyl)-(1f2)-(3,4-di-O-ben zyl-6-O-(2-(N-ben zyloxy-
ca r bon yl)a m in oeth yl-p h osp h on a to)-r-D-m a n n op yr a n o-
syl)-(1f2)-(3,4,6-tr i-O-ben zyl-r-D-m an n opyr an osyl)-(1f6)-
[(2-a cet a m id o-3,4,6-t r i-O-b en zyl-2-d eoxy-â-D-ga la ct op y-
r a n osyl)-(1f4)]-(3-O-ben zyl-r-D-m a n n op yr a n osyl)-(1f4)-
(3,6-d i-O-b e n zyl-2-N -(t er t -b u t yloxyca r b on yl)a m in o-2-
d e oxy-r-D-glu cop yr a n osyl)-(1f6)-2,3,4,5-t e t r a -O-b e n -
zyl-1-O-ben zoyl-m yo-in ositol (41). Compound 40 (125 mg,
39 µmol), compound 2 (92 mg, 230 µmol), and tetrazole (16
mg, 230 µmol) were dried in a vacuum for 2 h. After addition
of 2.5 mL of dry CH2Cl2, the solution was stirred at room
temperature under argon for 3 h and MCPBA (70%) (56 mg,
230 µmol) was added. The solution was stirred for another 2
h and then 2 mLof MeNH2 solution (33% in dry ethanol) was
added. After stirring for an additional hour, removal of the
solvent, and flash chromatography (4 g silica gel, toluene/ethyl
acetate 95:5 f 9:1 f 8:2 f 7:3 f 6:4 f 1:1 f 1:2) compound
41 (96 mg, 29 µmol, 74%) was obtained as a colorless foam.
(2,3,4,6-Tet r a -O-b en zyl-r-D-m a n n op yr a n osyl)-(1f2)-
(3,4-di-O-ben zyl-6-O-ter t-bu tyldiph en ylsilyl-r-D-m an n opy-
r a n osyl)-(1f2)-(3,4,6-tr i-O-ben zyl-r-D-m a n n op yr a n osyl)-
(1f6)-[(2-a c e t a m id o -3,4,6-t r i-O -b e n zy l-2-d e o x y -â-D -
galactopyr an osyl)-(1f4)]-(3-O-ben zyl-2-O-ph en oxyacetyl-
r-D-m a n n op yr a n osyl)-(1f4)-(3,6-d i-O-b en zyl-2-N-(ter t-
b u t yloxyca r b on yl)a m in o-2-d eoxy-r-D-glu cop yr a n osyl)-
(1f6)-2,3,4,5-tetr a-O-ben zyl-1-O-ben zoyl-myo-in ositol (39).
Compound 6 (90 mg, 83 µmol) and trichloroacetimidate 5 (230
mg, 90 µmol) were dissolved under argon in 1.3 mL of dry CH2-
Cl2 and cooled to 0 °C. After addition of a 0.1 N TMSOTf
solution (85 µL, 8.5 µmol) and stirring at 0 °C for 1 h the
solution was neutralized with triethylamine. Removal of the
solvent and flash chromatography (petroleum ether/ethyl
acetate 3:1) with subsequent MPLC afforded compound 39 (213
mg, 61 µmol, 74%), which could be lyophilized from dioxane.
TLC [HPTLC, petroleum ether/ethyl acetate (2:1)] Rf 0.63; [R]D
1
TLC [toluene/ethyl acetate (1:1)] Rf 0.4; H NMR (250 MHz,
t
CDCl3/d4-MeOH 2:1) δ 1.11 (s, 9H, Bu), 1.83 (s, 3H, NAc),
2.61-2.73 (m, 2H), 3.18-5.37 (m, 88H), 7.05-7.61 (m, 103H,
Ph), 8.01-8.04 (m, 2H, Bz); HMQC data (13C (150.9 MHz)/1H
(600 MHz)) 74.8/5.08 (1a), 73.7/4.23 (2a), 80.4/3.63 (3a), 81.4/
4.13 (4a), 79.7/3.50 (5a), -/4.47 (6a), 98.0/5.32 (1b), 54.2/3.79
(2b), 80.3/3.48 (3b), 73.8/4.02 (4b), 70.5/4.04 (5b), 68.4/3.48 (6b),
101.4/5.10 (1c), 68.7/3.86 (2c), 77.3/3.67 (3c), (4c), 71.3/3.64 (5c),
101.5/4.65 (1d), 52.1/4.31 (2d), 81.2/3.51 (3d), 71.8/3.62 (4d),
98.7/4.89 (1e), 73.1/4.11 (2e), 80.1/3.90 (3e), 74.8/3.65 (4e), 71.8/
3.80 (5e), 100.0/5.16 (1f), (73.5/4.182f), 79.0/3.87 (3f), 74.2/4.01
(4f), 98.8/5.19 (1g), 74.5/3.84 (2g), 79.2/3.86 (3g), 74.2/4.01 (4g);
31P NMR (242.94 MHz, CDCl3) δ -1.43. Anal. Calcd for
C199H214O43N3P (3367.13): C 69.70, H 6.30, N 1.22. Found: C
1
+10 (c 1.0, CDCl3); H NMR (250 MHz, CDCl3) δ 0.98 (s, 9H,
tBu), 1.11 (s, 9H, Boc), 1.58 (s, 3H, NAc), 3.10-5.08 (m, 81H),
5.20-5.35 (m, 4H, 1b-H, 1c-H, 1f-H, 1g-H), 5.50 (m, 1H,
2c-H), 6.12 (d, J NH ) 9.2 Hz, 1H, NH), 6.51-6.58 (m, 2H, PA),
6.76-6.85 (m, 1H, PA), 6.90-7.55 (m, 109H, Ph), 7.62-7.73
1306 J . Org. Chem., Vol. 68, No. 4, 2003